reference/31517145

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31517145

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	528
issn	0735-1097
issueIdentifier	3
pageRange	522-528
publicationName	Journal of the American College of Cardiology
startingPage	522
bibliographicCitation	Bolognese L, Falsini G, Liistro F, Angioli P, Ducci K, Taddei T, Tarducci R, Cosmi F, Baldassarre S, Burali A. Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial. J Am Coll Cardiol. 2006 Feb 07;47(3):522–8. doi: 10.1016/j.jacc.2005.11.012. PMID: 16458130.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7b6d48d24af051c02ff8a3b4fccdc23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fdab518d866fb854cdf02c9531537af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3c503bba55b6b2b603a81b6ac45ee70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b625ced9ff4774068d3e6f9cfd4d446 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9bbb3f3c2f8ab4e2188e45daaf836adb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90480c800f329f7dd107b2095cc66c45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43e6e18ad95d65a907f7a270f4681761 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64b3b4b7f09007253a5bef629198a426 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19e9441891eae6e653c27da0fa097043 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5630483cde426b7d5a215260575c0a98
date	2006-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/16458130 https://doi.org/10.1016/j.jacc.2005.11.012
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4429 https://portal.issn.org/resource/ISSN/0735-1097
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial
discusses	http://id.nlm.nih.gov/mesh/M0028614 http://id.nlm.nih.gov/mesh/M0011126 http://id.nlm.nih.gov/mesh/M0227707 http://id.nlm.nih.gov/mesh/M0022203 http://id.nlm.nih.gov/mesh/M0028424 http://id.nlm.nih.gov/mesh/M0211213 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0017012
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D019039Q000037 http://id.nlm.nih.gov/mesh/D007140Q000008 http://id.nlm.nih.gov/mesh/D019210Q000097 http://id.nlm.nih.gov/mesh/D003326 http://id.nlm.nih.gov/mesh/D015906 http://id.nlm.nih.gov/mesh/D003327Q000188 http://id.nlm.nih.gov/mesh/D010975Q000008 http://id.nlm.nih.gov/mesh/D014443Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000077466 http://id.nlm.nih.gov/mesh/D000077284 http://id.nlm.nih.gov/mesh/D004562 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D003327Q000628 http://id.nlm.nih.gov/mesh/D004452 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003327Q000503 http://id.nlm.nih.gov/mesh/D014443Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8563 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654660

Total number of triples: 59.